ScholarIQanswers from OpenAlex

Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.

PaperCitations, authors & open-access status

Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. have?

ScholarIQcitation count

Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. has 108 citations in the OpenAlex counts ScholarIQ stores.

When was Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. published?

ScholarIQyear

Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. has 2002 year in the ScholarIQ index.

What is the open-access status of Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.?

ScholarIQoa status

Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. has green oa status in the ScholarIQ index.

What is the PMID of Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.?

ScholarIQpmid

The PMID for Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. is on the source record.

What is the OpenAlex record for Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.?

ScholarIQopenalex

The OpenAlex for Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial